Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 8/20 | 0.38 |
| ▸ | MAOA | P21397 | 7/20 | 0.38 |
| ▸ | KDM1A | O60341 | 5/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.38 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10957391 | 0.83 | KDM1A (0.33) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL18919015 | 0.80 | — | — | |
| SCHEMBL3096275 | 0.77 | MAOB (0.38) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL3096287 | 0.77 | MAOB (0.38) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL1157784 | 0.75 | TSHR (0.36) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL132148 | 0.75 | TSHR (0.36) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL11573778 | 0.73 | TSHR (0.39) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL28470973 | 0.73 | HSD17B10 (0.37) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL3078602 | 0.73 | KDM4E (0.52) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL20960545 | 0.72 | KDM1A (0.35) | MAOBMAOAKDM1ALMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2650274-B1 | A thionation process and a thionating agent | VIRONOVA THIONATION AB (SE) | 2019-05-01 | — | — | EP | disclosed |
| US-9221855-B2 | Thionation process and a thionating agent | VIRONOVA THIONATION AB (SE) | 2015-12-29 | — | — | US | disclosed |
| US-9221855-B2 | Thionation process and a thionating agent | VIRONOVA THIONATION AB (SE) | 2015-12-29 | — | — | US | disclosed |
| US-9115158-B2 | Thionating agent | VIRONOVA THIONATION AB (SE) | 2015-08-25 | — | — | US | disclosed |
| US-9115158-B2 | Thionating agent | VIRONOVA THIONATION AB (SE) | 2015-08-25 | — | — | US | disclosed |
| US-20130303767-A1 | THIONATING AGENT | VIRONOVA THIONATION AB (SE) | 2013-11-14 | — | — | US | disclosed |
| US-20130303767-A1 | THIONATING AGENT | VIRONOVA THIONATION AB (SE) | 2013-11-14 | — | — | US | disclosed |
| EP-2569263-B1 | A THIONATION PROCESS AND A THIONATING AGENT | VIRONOVA AB (SE) | 2013-11-13 | — | — | EP | disclosed |
| EP-2650274-A2 | A thionation process and a thionating agent | Vironova AB (SE) | 2013-10-16 | — | — | EP | disclosed |
| US-20130102774-A1 | THIONATION PROCESS AND A THIONATING AGENT | VIRONOVA AB (SE) | 2013-04-25 | — | — | US | disclosed |
| US-20130102774-A1 | THIONATION PROCESS AND A THIONATING AGENT | VIRONOVA AB (SE) | 2013-04-25 | — | — | US | disclosed |
| WO-2012104415-A1 | A THIONATION PROCESS AND A THIONATING AGENT | VIRONOVA AB (SE) | 2012-08-09 | — | — | WO | disclosed |
| EP-2484655-A1 | A thionation process and a thionating agent | Vironova AB (SE) | 2012-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130102774-A1 | THIONATION PROCESS AND A THIONATING AGENT | NT5M, NT5E, NUDT5 | TSHR 1268/4885MAOB 2494/4885MAOA 2643/4885 |
| US-20130303767-A1 | THIONATING AGENT | NT5E, NT5C2, NUDT5 | TSHR 1626/4885MAOB 2390/4885MAOA 2312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.